scholarly journals Molecular breast imaging will soon replace x-ray mammography as the imaging modality of choice for women at high risk with dense breasts

2009 ◽  
Vol 36 (5) ◽  
pp. 1463-1466 ◽  
Author(s):  
Michael K. O’Connor ◽  
Georgia Tourassi ◽  
Colin G. Orton
2019 ◽  
Vol 7 (3) ◽  
pp. 442-444 ◽  
Author(s):  
Naziya Samreen ◽  
Katie N. Hunt ◽  
Carrie B. Hruska ◽  
Deborah J. Rhodes

Author(s):  
Mark B. Williams ◽  
Patricia G. Judy ◽  
Zongyi Gong ◽  
Audrey E. Graham ◽  
Stan Majewski ◽  
...  

2015 ◽  
Vol 204 (2) ◽  
pp. 241-251 ◽  
Author(s):  
Deborah J. Rhodes ◽  
Carrie B. Hruska ◽  
Amy Lynn Conners ◽  
Cindy L. Tortorelli ◽  
Robert W. Maxwell ◽  
...  

2020 ◽  
Vol 2 (5) ◽  
pp. 484-491
Author(s):  
Beatriz E Adrada ◽  
Tanya Moseley ◽  
S Cheenu Kappadath ◽  
Gary J Whitman ◽  
Gaiane M Rauch

Abstract Molecular breast imaging (MBI) is an increasingly recognized nuclear medicine imaging modality to detect breast lesions suspicious for malignancy. Recent advances have allowed the development of tissue sampling of MBI-detected lesions using a single-headed camera (breast-specific gamma imaging system) or a dual-headed camera system (MBI system). In this article, we will review current indications of MBI, differences of the two single- and dual-headed camera systems, the appropriate selection of biopsy equipment, billing considerations, and radiation safety. It will also include practical considerations and guidance on how to integrate MBI and MBI-guided biopsy in the current breast imaging workflow.


2015 ◽  
Vol 204 (6) ◽  
pp. 1345-1353 ◽  
Author(s):  
Carrie B. Hruska ◽  
Amy Lynn Conners ◽  
Katie N. Jones ◽  
Michael K. O'Connor ◽  
James P. Moriarty ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document